Jonathan Mark Elkins

Jon is a researcher and Principal Investigator, Cellular Signalling and Biotechnology, at the Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford. The CMD is an academic centre focussed on the discovery of early-stage drugs. Jon has more than 25 years experience as a researcher at the University of Oxford (UK).From 2016 to 2018 he was the scientific director of the SGC (Structural Genomics Consortium) lab at the Centre for Medicinal Chemistry (CQMED) at UNICAMP. The SGC-UNICAMP lab was part of an International collaborative Open Science Project funded by PITE FAPESP. The SGC is an international consortium with, at the time, laboratories in five countries whose mission is to accelerate research in new areas of biology, focussing on areas of the human genome that are less well studied.In recent years, Jons research has centred on protein kinases and other families of proteins involved in cellular signalling. He has experience in the areas of Chemistry, Biochemistry and Structural Biology, and his research determines protein structures and develops chemical inhibitors of those proteins. These inhibitors can be used to investigate the function of the proteins in cells and can be developed into drugs.He has a degree and PhD in chemistry from the University of Oxford (1998 and 2002). He did post-doctoral research in the group of Prof. Christopher J. Schofield working to understand proteins involved in hypoxic regulation and antibiotic biosynthesis. (Source: Lattes Curriculum)